12-Lipoxygenase: A Potential Target for Novel Anti-Platelet Therapeutics

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 9, Iss. 3, 2011-07 ,pp. : 154-164

Bentham Science Publishers

Access to resources Recommend Favorite

Follow-up of coeliac disease with the novel one-hour ¹³C-sorbitol breath test versus the H₂-sorbitol breath test

By Tveito Kari   Hetta Anne Kristine   Askedal Mia   Brunborg Cathrine   Sandvik Leiv   Løøberg Else Marit   Skar Viggo  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 7-8, 2011-07 ,pp. : 837-843

Informa Healthcare

Access to resources Recommend Favorite

A novel one-hour13C-sorbitol breath test versus the H2-sorbitol breath test for assessment of coeliac disease

By Tveito Kari   Hetta Anne Kristine   Askedal Mia   Brunborg Cathrine   Sandvik Leiv   Løberg Else Marit   Skar Viggo  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 7, 2009-07 ,pp. : 813-819

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing “one-stop” hybrid coronary revascularization

By Gao Peixian   Xiong Hui   Zheng Zhe   Li Lihuan   Gao Runlin   Hu Sheng-Shou  

Platelets, Vol. 21, Iss. 3, 2010-11 ,pp. : 183-190

Informa Healthcare

Access to resources Recommend Favorite

Future Prospects in Anti-Platelet Therapy: A Review of Potential P2Y12 and Thrombin Receptor Antagonists

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. : 194-200

Bentham Science Publishers

Access to resources Recommend Favorite